Lung cancer metabolomic data from tumor core biopsies enables risk-score calculation for progression-free and overall survival.
- Published in:
- Metabolomics, 2022, v. 18, n. 5, p. 1, doi. 10.1007/s11306-022-01891-x
- By:
- Publication type:
- Article
Works matching IS 15733882 AND DT 2022 AND VI 18 AND IP 5
Results: 6
1
2
Metabotyping the Welsh population of badgers based on thoracic fluid.
- Published in:
- Metabolomics, 2022, v. 18, n. 5, p. 1, doi. 10.1007/s11306-022-01888-6
- By:
- Publication type:
- Article
3
Temporal profile of serum metabolites and inflammation following closed head injury in rats is associated with HPA axis hyperactivity.
- Published in:
- Metabolomics, 2022, v. 18, n. 5, p. 1, doi. 10.1007/s11306-022-01886-8
- By:
- Publication type:
- Article
4
Establishing pteridine metabolism in a progressive isogenic breast cancer cell model – part II.
- Published in:
- Metabolomics, 2022, v. 18, n. 5, p. 1, doi. 10.1007/s11306-022-01885-9
- By:
- Publication type:
- Article
5
Serum metabolomic profiling for patients with adenocarcinoma of the esophagogastric junction.
- Published in:
- Metabolomics, 2022, v. 18, n. 5, p. 1, doi. 10.1007/s11306-022-01883-x
- By:
- Publication type:
- Article
6
An evaluation of the National Institutes of Health grants portfolio: identifying opportunities and challenges for multi-omics research that leverage metabolomics data.
- Published in:
- Metabolomics, 2022, v. 18, n. 5, p. 1, doi. 10.1007/s11306-022-01878-8
- By:
- Publication type:
- Article